Merrimack Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
MACK Nasdaq 8731 http://www.merrimackpharma.com 5.91 Stock Up +0.48

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Merrimack Pharmaceuticals Inc

Should You Worry About the Short Interest in Merrimack (MACK)? - Mar 5th, 2014 7:33 am
MERRIMACK PHARMACEUTICALS INC Files SEC form 10-K, Annual Report - Mar 4th, 2014 2:18 pm
Merrimack Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript - Feb 27th, 2014 5:31 pm
Merrimack Provides Fourth Quarter and Full Year 2013 Financial Results - Feb 27th, 2014 2:34 pm
MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements - Feb 27th, 2014 2:21 pm
Merrimack Provides Fourth Quarter and Full Year 2013 Financial Results - Feb 27th, 2014 2:01 pm
Today's Biggest Stories in Biotech: Galectin Therapeutics Inc, Merrimack Pharmaceuticals and Nektar Therapeutics - Feb 27th, 2014 7:27 am
Q4 2013 Merrimack Pharmaceuticals Inc Earnings Release - After Market Close - Feb 27th, 2014 5:07 am
Merrimack to Present at the Cowen and Company 34th Annual Health Care Conference - Feb 24th, 2014 7:16 am
Merrimack to Present at the Cowen and Company 34th Annual Health Care Conference - Feb 24th, 2014 6:00 am
Merrimack Announces Timing of Fourth Quarter 2013 Investor Conference Call - Feb 20th, 2014 4:21 pm
Merrimack Announces Timing of Fourth Quarter 2013 Investor Conference Call - Feb 20th, 2014 2:05 pm
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics - Feb 18th, 2014 7:05 am
Preclinical Study Results of Merrimack's MM-141 Published in Molecular Cancer Therapeutics - Feb 18th, 2014 6:00 am
MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers - Feb 14th, 2014 2:28 pm
Merrimack Initiates Phase 1 Clinical Study of MM-398 in Combination With Cyclophosphamide for Pediatric Solid Tumors - Jan 23rd, 2014 6:08 am
Merrimack Initiates Phase 1 Clinical Study of MM-398 in Combination With Cyclophosphamide for Pediatric Solid Tumors - Jan 23rd, 2014 6:00 am
Merrimack to Present Preclinical Data at the American Society of Clinical Oncology (ASCO) 2014 Gastrointestinal Cancers Symposium - Jan 13th, 2014 6:34 am
Merrimack to Present Preclinical Data at the American Society of Clinical Oncology (ASCO) 2014 Gastrointestinal Cancers Symposium - Jan 13th, 2014 6:00 am
[$$] Best Biotech Ideas for 2014 - Jan 10th, 2014 12:54 pm